Cell and Gene Outsourcing

  1. Tariffs, FDA Chaos, And BioSecure: How CDMOs Should Operate 8/3/2026

    Tariffs, FDA workforce cuts, and a stalled BioSecure Act are reshaping CDMO strategy. Get the full policy breakdown to stress-test your supply chain planning now.

  2. 6 CMC Strategies Are Transforming Biologics Drug Development 8/3/2026

    Sid Jain's two decades across Novartis, Regeneron, and Sanofi reveal six CMC strategies redefining how biologics reach the clinic, from CDMO selection to digital transformation pitfalls.

  3. AI Tools In Informed Consent: What Sponsors Need To Know About Risk 8/1/2026

    AI tools carry different risks. See how they can impact participant communications, where bias and inaccuracies emerge, and why human review is critical to protecting study integrity.

  4. What To Get Right Early In Subcutaneous Biologics Development 7/31/2026

    High-concentration biologics can face viscosity and aggregation challenges. Early modeling and targeted testing optimize formulations for stability, manufacturability, and delivery.

  5. June 2026 — CDMO Opportunities And Threats Report 7/30/2026

    Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

  6. Webinar Highlights: The Missing Layer Holding Lab Operations Back 7/30/2026

    Scientific work depends on more than data alone. Learn how connected process context, decision logic, deviation tracking, and workflow orchestration can help teams improve traceability and execution.

  7. Workflow Orchestration Solution For Pharmaceutical Development 7/30/2026

    Disconnected handoffs, scattered data, and manual coordination can slow scientific progress. Learn how connected workflow orchestration helps teams improve visibility, reduce bottlenecks, and more.

  8. Manufacture Where Care Happens With LENTIVERSE™ LaunchSuit 7/29/2026

    Point-of-care manufacturing streamlines cell therapy from patient material to final release in seven days, using integrated reagents and standardized workflows to reduce costs.

  9. Turn Future Therapies Into Product Realities 7/29/2026

    Balancing speed, quality, and cost is key in cell therapy manufacturing. Streamlined design and scalable platforms shorten timelines, sustain high yields, and lower costs.

  10. The Decision Rights Matrix: Making Sponsor-CDMO Governance Enforceable 7/29/2026

    In LVV manufacturing, the quality target product profile and the DRM are designed to work together. One defines what is being governed, the other names who governs it.